anti-DEC-205 antibody vaccine (EpiVax)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-DEC-205 antibody vaccine (EpiVax)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionT lymphocytes modulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEpiVax Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEpiVax Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A